Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma-Reference-Cited by-同舟云学术

Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma

Published:2006 Issue:11 Volume:54 Page:3661-3669
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Wu Sou-Pan,Leng Lin,Feng Zeny,Liu Nianjun,Zhao Hongyu,McDonald Courtney,Lee Annette,Arnett Frank C.,Gregersen Peter K.,Mayes Maureen D.,Bucala Richard

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference46 articles.

1. Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts

2. Genetics of scleroderma: update on single nucleotide polymorphism analysis and microarrays

3. Association of microsatellite markers near the fibrillin 1 gene on human chromosome 15q with scleroderma in a Native American population

4. HLA and ethnic associations among systemic sclerosis patients with anticentromere antibodies

5. HLA associations in three mutually exclusive autoantibody subgroups in UK systemic sclerosis patients

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenetics of Systemic Sclerosis;Genes;2024-05-05

2. Role of regulatory T cells in pathogenesis and therapeutics of scleroderma (systemic sclerosis);Regulatory T Cells and Autoimmune Diseases;2024

3. Deep Insight into the Role of MIF in Spondyloarthritis;Current Rheumatology Reports;2022-07-09

4. The Immunogenetics of Systemic Sclerosis;The Immunogenetics of Dermatologic Diseases;2022

5. Cellular and Molecular Diversity in Scleroderma;Seminars in Immunology;2021-12